Gabexate mesylate is widely used in medical settings as a protease inhibitor, particularly in the treatment of acute pancreatitis. It helps reduce inflammation by inhibiting the activity of proteolytic enzymes, which are often overactive in this condition. Additionally, it is employed during procedures like hemodialysis and extracorporeal circulation to prevent blood clotting and minimize the risk of thrombosis. Its anticoagulant properties make it useful in managing conditions where blood clot formation is a concern. Gabexate mesylate is also studied for its potential in treating disseminated intravascular coagulation (DIC) due to its ability to modulate coagulation and fibrinolysis pathways.